Deborah Shnek

Executive Director, Drug Product Technology at Resilience

Role
Executive Director, Drug Product Technology at Resilience
Location
Seattle, WA, US
LinkedIn followers
500 followers

About Deborah Shnek

Seasoned leader specializing in commercializing biotech products. I have successfully scaled-up mABs, vaccines (gene therapy), proteins, and antibody drug conjugates. Provided manufacturing solutions for both early and late stages of biopharmaceutical development including combination products-Commercialization CMC strategy for biologics including monoclonal antibodies, vaccines, peptides, conjugate antibodies, fusion proteins including combination product - device strategy-Capital projects and commissioning -CQA strategy development and comparability protocols-Bioprocess development of microbial and mammalian cells-Scale-up / technology transfer for Phase I through late stage including CMO selection for drug substance and drug product. Experienced author providing process transfer documents, process characterization protocols, stability studies, and scope of work-Regulatory document preparation: IND through marketing application-Selection of contract manufacturing, process characterization strategy and validation. Specialties: Process development, technology transfer, process characterization, comparability, statistical analysis, experimental design, formulation development for frozen, liquid, controlled release, and lyophilized drug products in cartridges, vials, syringes and devices.

Experience

  1. Executive Director, Drug Product Technology

    Resilience

    Mar 2021 — Present

    Responsible for drug product technology across the Resilience network.

Education

  • Caltech

    PhD, Chemical Engineering

  • Massachusetts Institute of Technology

    B.S., Chemical Engineering

  • Caltech

    M.S., Chemical Engineering

Skills

  • Protein Chemistry
  • Antibodies
  • Commercialization
  • Machine Vision
  • Lifesciences
  • Purification
  • Fda
  • Formulation
  • Gmp
  • Process Validation
  • Vaccines
  • Product Development
  • Technology Transfer
  • Monoclonal Antibodies
  • Regulatory Requirements
  • Ind
  • Manual Inspection, Automated Inspection, Biologics, Regulatory Filings
  • Automated Inspection
  • Life Sciences
  • Biologics
  • Manufacturing
  • V&V
  • Process Simulation
  • Stability Studies
  • Validation
  • Biotechnology
  • Regulatory Submissions
  • Combination Products
  • Drug Development
  • Medical Devices
  • Biopharmaceuticals
  • Characterization

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Deborah Shnek — Executive Director, Drug Product Technology at Resilience in Seattle, WA, US | Unifers